[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.236.145.124. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 954
Citations 0
Editorial
January 10, 2019

Drivers of Clinical Trial Participation—Demographics, Disparities, and Eligibility Criteria

Author Affiliations
  • 1Cancer Therapy Evaluation Program, Clinical Investigations and Investigational Drug Branches, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland
JAMA Oncol. 2019;5(3):305-306. doi:10.1001/jamaoncol.2018.5949

In the current issue of JAMA Oncology, Unger et al1 provide an overview from SWOG in response to the recommendations to modernize eligibility criteria for clinical trials developed by the American Society of Oncology (ASCO), Friends of Cancer Research (Friends), and the National Cancer Institute (NCI) to support less restrictive eligibility criteria to broaden participation in clinical trials.2-6

×